Basic Chemical Industries Company
TADAWUL:1210.SR
30.35 (SAR) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 741.108 | 674.666 | 513.379 | 500.24 | 534.561 | 605.19 | 595.54 | 557.826 | 625.131 | 633.456 | 658.951 | 704.6 | 642.73 | 543.887 | 508.742 | 494.219 | 424.194 |
Cost of Revenue
| 574.556 | 498.52 | 369.617 | 368.942 | 400.023 | 450.405 | 444.747 | 412.72 | 483.719 | 498.479 | 497.869 | 512.741 | 469.362 | 396.192 | 357.988 | 363.445 | 300.193 |
Gross Profit
| 166.551 | 176.145 | 143.762 | 131.298 | 134.539 | 154.785 | 150.794 | 145.106 | 141.413 | 134.977 | 161.082 | 191.859 | 173.368 | 147.695 | 150.754 | 130.774 | 124.001 |
Gross Profit Ratio
| 0.225 | 0.261 | 0.28 | 0.262 | 0.252 | 0.256 | 0.253 | 0.26 | 0.226 | 0.213 | 0.244 | 0.272 | 0.27 | 0.272 | 0.296 | 0.265 | 0.292 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 23.443 | 7.924 | 6.741 | 6.443 | 7.523 | 7.38 | 7.051 | 24.978 | 25.665 | 34.068 | 29.596 | 82.355 | 75.544 | 68.744 | 66.025 | 65.118 | 53.71 |
Selling & Marketing Expenses
| 75.747 | 33.094 | 21.694 | 23.681 | 22.857 | 25.021 | 27.688 | 47.552 | 48.296 | 47.586 | 50.751 | 47.445 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 99.189 | 41.018 | 28.435 | 30.124 | 30.38 | 32.401 | 34.74 | 72.53 | 73.961 | 81.654 | 80.347 | 82.355 | 75.544 | 68.744 | 66.025 | 65.118 | 53.71 |
Other Expenses
| -94.37 | 40.134 | 40.409 | 33.649 | 34.961 | 40.23 | 0 | 5.048 | 3.734 | 4.654 | 0.301 | 0 | 0 | 0 | 0 | -27.134 | -22.566 |
Operating Expenses
| 86.84 | 81.152 | 68.845 | 63.773 | 65.341 | 72.631 | 64.243 | 72.53 | 73.961 | 81.654 | 80.347 | 82.355 | 148.51 | 135.872 | 131.046 | 128.025 | 107.42 |
Operating Income
| 76.698 | 81.432 | 74.394 | 67.525 | 69.198 | 82.154 | 86.55 | -72.577 | 67.451 | 53.323 | 80.736 | 109.504 | 24.858 | 11.823 | 19.708 | 2.749 | 16.581 |
Operating Income Ratio
| 0.103 | 0.121 | 0.145 | 0.135 | 0.129 | 0.136 | 0.145 | -0.13 | 0.108 | 0.084 | 0.123 | 0.155 | 0.039 | 0.022 | 0.039 | 0.006 | 0.039 |
Total Other Income Expenses Net
| -21.167 | -1.399 | -5.592 | -0.137 | -0.159 | 0.726 | 0.808 | 152.85 | 3.969 | 5.001 | 0.502 | 72.429 | 140.431 | 152.054 | 131.124 | 127.965 | 36.072 |
Income Before Tax
| 55.531 | 80.033 | 68.802 | 67.388 | 69.039 | 82.88 | 87.359 | 80.273 | 71.421 | 58.324 | 81.238 | 181.933 | 165.289 | 163.877 | 150.832 | 130.714 | 52.653 |
Income Before Tax Ratio
| 0.075 | 0.119 | 0.134 | 0.135 | 0.129 | 0.137 | 0.147 | 0.144 | 0.114 | 0.092 | 0.123 | 0.258 | 0.257 | 0.301 | 0.296 | 0.264 | 0.124 |
Income Tax Expense
| 11.546 | 9.638 | 11.083 | 9.098 | 9.653 | 12.361 | 15.605 | 8.848 | 7.887 | 7.507 | 8.288 | 37.075 | 34.701 | 21.231 | 20.634 | 5.023 | 4.23 |
Net Income
| 5.518 | 70.395 | 57.719 | 58.29 | 59.386 | 49.668 | 43.769 | 43.482 | 34.536 | 23.913 | 44.329 | 56.473 | 59.306 | 66.211 | 62.651 | 39.637 | 48.423 |
Net Income Ratio
| 0.007 | 0.104 | 0.112 | 0.117 | 0.111 | 0.082 | 0.073 | 0.078 | 0.055 | 0.038 | 0.067 | 0.08 | 0.092 | 0.122 | 0.123 | 0.08 | 0.114 |
EPS
| 0.2 | 2.56 | 2.1 | 2.12 | 2.16 | 1.81 | 1.59 | 1.58 | 1.26 | 0.87 | 1.61 | 2.05 | 0 | 0 | 0 | 0 | 1.76 |
EPS Diluted
| 0.2 | 2.56 | 2.1 | 2.12 | 2.16 | 1.81 | 1.59 | 1.58 | 1.26 | 0.87 | 1.61 | 2.05 | 0 | 0 | 0 | 0 | 1.76 |
EBITDA
| 115.493 | 118.116 | 93.564 | 95.604 | 97.544 | 109.264 | 115.068 | 101.271 | 96.769 | 77.558 | 103.207 | 131.358 | 46.336 | 33.268 | 40.655 | 24.545 | 37.825 |
EBITDA Ratio
| 0.156 | 0.175 | 0.182 | 0.191 | 0.182 | 0.181 | 0.193 | 0.182 | 0.155 | 0.122 | 0.157 | 0.186 | 0.072 | 0.061 | 0.08 | 0.05 | 0.089 |